Supplements and Solifenacin.
Solifenacin, sold under the brand names Vesicare, Vesomni, is an antimuscarinic agent for urinary urgency or overactive bladder.
Solifenacin is an antimuscarinic agent for urinary urgency or overactive bladder. The class blocks muscarinic acetylcholine receptors in the detrusor muscle, reducing involuntary contraction. UK prescribing includes solifenacin, tolterodine, oxybutynin, and mirabegron (technically a beta-3 agonist but in the same prescribing space). The supplement surface includes additive anticholinergic burden, which matters most in older patients given the cognitive decline signal that has emerged in long anticholinergic exposure data. Supplements with anticholinergic potential at high doses (some choline pathway compounds in reverse, certain antiemetic herbals) warrant care. Dry mouth. Constipation. Urinary retention. All three scale with dose. The NICE NG123 guideline pushes for review of indication and dose every six to twelve months, given the cognitive burden picture.
Below are the 1 documented pair we have explicitly assessed against Solifenacin in the Distil database: 1 amber. The pairs cluster around 1 mechanism: Cholinergic vs anticholinergic (opposing). Every call is cited to either a clinical reference (PMID) or the British National Formulary. Anything not on this list is either still to be assessed or beyond our database scope. The checker beneath surfaces assessments by supplement, and the missing-item form at the bottom of the page routes any uncatalogued supplement into our next curation pass.
Documented interactions
Cholinergic vs anticholinergic (opposing)
Huperzine A raises acetylcholine while solifenacin blocks it, so each can work against the other. Huperzine A may make solifenacin less effective for bladder symptoms, and solifenacin may blunt any benefit from huperzine A. It is not dangerous, but the two are pulling in opposite directions, so it is worth a word with your prescriber.
Reviewer-flagged: awaiting clinical-reviewer sign-off.
What this list does not say. Pairs not flagged here are not implicitly safe. They are either not yet in our database, or fall outside our inclusion scope (food-supplement interactions only; for drug-drug interactions, the BNF is authoritative). Use the checker below to surface any supplement, and submit a missing item if you take something we have not catalogued.
How we grade severity, choose what's in scope, and what we exclude.
Every call on this page is reasoned. We publish the full rubric for severity tiers, the medication inclusion logic, the evidence grades we accept, and what we deliberately leave out. About three thousand words. Worth reading once if you use this tool more than occasionally.
Read the full methodologyWant this checked across everything you take?
This page checks the pairs you enter. The personalised Distil report goes further:
- the same graded, cited interaction check across your whole stack, not just the pairs you thought to type in
- where your current routine may be leaving you short of your goals
- the evidence-backed compounds worth adding, and the ones worth dropping
It's a paid report: £79, or £49 for the first 25 customers. The interactions check is one section of it, and you can read a real one in full before you buy.
See a real sample reportSomething missing?
If a supplement or medication you take isn't in our autocomplete, tell us. We go through what people flag every week and add what's missing.